ImmuCell Corp (ICCC)

4.45 -0.01  -0.28% NASDAQ Jun 3, 20:00 Delayed 2m USD

ImmuCell Profit Margin (Quarterly):

-2.49% for March 31, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Profit Margin (Quarterly) Chart

Export Data
Save Image
Print Image

Historical Profit Margin (Quarterly) Data

View and export this data going back to 1989. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
March 31, 2020 -2.49%
Dec. 31, 2019 -8.55%
Sept. 30, 2019 -16.92%
June 30, 2019 -23.14%
March 31, 2019 3.28%
Dec. 31, 2018 -35.83%
Sept. 30, 2018 -11.61%
June 30, 2018 -26.48%
March 31, 2018 -7.67%
Dec. 31, 2017 -6.21%
Sept. 30, 2017 -16.93%
June 30, 2017 -12.48%
March 31, 2017 16.49%
Dec. 31, 2016 1.37%
Sept. 30, 2016 1.77%
June 30, 2016 -0.39%
March 31, 2016 15.15%
Dec. 31, 2015 10.72%
Sept. 30, 2015 14.21%
June 30, 2015 4.80%
March 31, 2015 15.45%
Dec. 31, 2014 5.92%
Sept. 30, 2014 0.58%
June 30, 2014 -19.15%
March 31, 2014 -0.64%
   
Dec. 31, 2013 -9.67%
Sept. 30, 2013 4.64%
June 30, 2013 0.47%
March 31, 2013 11.06%
Dec. 31, 2012 -1.19%
Sept. 30, 2012 -5.90%
June 30, 2012 1.29%
March 31, 2012 9.01%
Dec. 31, 2011 -0.04%
Sept. 30, 2011 -12.72%
June 30, 2011 -20.70%
March 31, 2011 -1.49%
Dec. 31, 2010 -11.39%
Sept. 30, 2010 -22.56%
June 30, 2010 -0.60%
March 31, 2010 -4.06%
Dec. 31, 2009 -1.47%
Sept. 30, 2009 -1.87%
June 30, 2009 -14.76%
March 31, 2009 -2.37%
Dec. 31, 2008 -3.20%
Sept. 30, 2008 -29.05%
June 30, 2008 -28.78%
March 31, 2008 4.75%
Dec. 31, 2007 4.77%

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Benchmarks

Benchmarks
Emergent BioSolutions Inc -6.49%
Johnson & Johnson 28.01%
Fate Therapeutics Inc -1.33K%

Profit Margin (Quarterly) Range, Past 5 Years

Minimum -35.83% Dec 2018
Maximum 16.49% Mar 2017
Average -5.05%
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.